Cancer@Work - a nurse-led, stepped-care, e-health intervention to enhance the return to work of patients with cancer: study protocol for a randomized controlled trial.
Cancer@Work - a nurse-led, stepped-care, e-health intervention to enhance the return to work of patients with cancer: study protocol for a randomized controlled trial.
复制标题
DOI：
10.1186/s13063-016-1578-8
复制
发表时间：
2016-09-15
期刊：
影响因子：
2.5
通讯作者：
de Boer AG
中科院分区：
文献类型：
--
作者：
Tamminga SJ;Hoving JL;Frings-Dresen MH;de Boer AG
虽然癌症患者的工作的重要性，现在更承认无论是在文献中，以及在癌症生存护理，针对这些患者的返回工作的有效干预措施仍然是稀缺的。因此，我们开发了一种以护士为主导的、阶梯式护理的电子健康干预措施，旨在提高癌症患者的重返工作岗位。本研究的目的是描述干预的内容和用于评估干预的可行性和（成本）效果的研究设计。我们设计了一项多中心随机对照试验，随访12个月。在诊断时有带薪工作、正在休病假且年龄在18-62岁之间的患者将有资格参加。在患者签署知情同意书并填写基线调查问卷后，他们被随机分配到护士主导的阶梯式护理，称为Cancer@Work的电子健康干预或照常护理。主要成果是可持续地重返工作岗位。次要结果是病假天数、工作能力、工作运作、生活质量、工作生活质量以及从最初请病假到完全恢复工作而无需广泛恢复的时间。将确定癌症@工作干预措施的可行性以及直接和间接成本。将在随访3、6、9和12个月时通过问卷调查评估结局。这项研究的结果将为Cancer@Work的可行性和（成本）效益提供新的见解，Cancer@Work是一项针对癌症患者的护士主导的阶梯式护理电子健康干预措施，旨在促进他们重返工作岗位。如果证明有效，其目的是在常规的心理肿瘤护理中实施癌症@工作干预。NTR（荷兰试验注册中心）：NTR 5190。于2015年6月18日注册。
Although the importance of work for patients with cancer is nowadays more acknowledged both in the literature as well as in cancer survivorship care, effective interventions targeting the return to work of these patients are still scarce. Therefore, we developed a nurse-led, stepped-care, e-health intervention aimed at enhancing the return to work of patients with cancer. The objective of this study is to describe the content of the intervention and the study design used to evaluate the feasibility and (cost) effectiveness of the intervention. We designed a multi-centre randomised controlled trial with a follow-up of 12 months. Patients who have paid employment at the time of diagnosis, are on sick leave and are between 18–62 years old will be eligible to participate. After patients have signed the informed consent form and filled in the baseline questionnaire, they are randomly allocated to either the nurse-led, stepped-care, e-health intervention called Cancer@Work, or care as usual. The primary outcome is sustainable return to work. Secondary outcomes are sick leave days, work ability, work functioning, quality of life, quality of working life and time from initial sick leave to full return to work without extensive need for recovery. The feasibility of the Cancer@Work intervention and direct and indirect costs will be determined. Outcomes will be assessed by questionnaires at 3, 6, 9 and 12 months of follow-up. The results of this study will provide new insights into the feasibility and (cost) effectiveness of Cancer@Work, a nurse-led, stepped-care, e-health intervention for cancer patients aimed at enhancing their return to work. If proven effective, the intention is to implement the Cancer@Work intervention in usual psycho-oncological care. NTR (Netherlands Trial Registry): NTR5190. Registered on 18 June 2015.
登录
查看更多内容
影响因子：
4
作者：
Hahn, Seokyung;Puffer, Suezann;Watson, Judith
通讯作者：
Watson, Judith
影响因子：
7.2
作者：
Gandek, B;Ware, JE;Sullivan, M
通讯作者：
Sullivan, M
影响因子：
3
作者：
Lerner, D;Amick, BC;Cynn, D
通讯作者：
Cynn, D
影响因子：
6.1
作者：
Lagerveld, Suzanne E.;Blonk, Roland W. B.;Schaufeli, Wilmar B.
通讯作者：
Schaufeli, Wilmar B.
DOI：
10.1136/bmj.e7586
发表时间：
2013-01-08
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Chan AW;Tetzlaff JM;Gøtzsche PC;Altman DG;Mann H;Berlin JA;Dickersin K;Hróbjartsson A;Schulz KF;Parulekar WR;Krleza-Jeric K;Laupacis A;Moher D
通讯作者：
Moher D